Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $6.3800 (4.93%) ($6.1100 - $6.5900) on Fri. Mar. 8, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.71% (three month average) | RSI | 74 | Latest Price | $6.3800(4.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -2.6% a day on average for past five trading days. | Weekly Trend | TGTX advances 15.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(64%) ARKG(57%) IBB(56%) IWO(56%) ARKK(55%) | Factors Impacting TGTX price | TGTX will decline at least -2.855% in a week (0% probabilities). VXX(-16%) UUP(-11%) TLT(-10%) VIXM(-8%) FIVG(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.855% (StdDev 5.71%) | Hourly BBV | 0 () | Intraday Trend | 4.2% | | | |
|
5 Day Moving Average | $6.41(-0.47%) | 10 Day Moving Average | $6.14(3.91%) | 20 Day Moving Average | $5.43(17.5%) | To recent high | -11.5% | To recent low | 27.6% | Market Cap | $808m | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |